Heart Disease Prevention for Men
Men experience cardiovascular events — heart attacks, strokes, sudden cardiac death — 7 to 10 years earlier than women on average. The first manifestation of coronary artery disease in men is more commonly a fatal heart attack rather than a warning episode of chest pain that prompts evaluation and treatment. Men die of cardiovascular disease at higher absolute rates than women at virtually every age until the late 60s and early 70s, when women’s postmenopausal cardiovascular acceleration narrows the gap. These are not minor statistical differences — they represent a fundamental divergence in cardiovascular trajectory between sexes that begins in young adulthood and compounds through every subsequent decade.
Yet despite this substantially elevated baseline risk, men are significantly less likely than women to have a regular primary care provider, attend routine preventive health visits, follow through on recommended cardiovascular screening, or seek care promptly when cardiovascular symptoms develop. This combination — higher cardiovascular risk with lower preventive healthcare engagement — is the defining challenge of heart disease prevention for men, and addressing it requires both clinical strategies that meet men where they are and individual men taking ownership of cardiovascular risk management that does not happen automatically through routine healthcare avoidance.
Why Men Have Earlier Cardiovascular Events — The Biology of Male Risk
The earlier onset of cardiovascular disease in men reflects several biological mechanisms that converge to produce less cardiovascular protection and more cardiovascular stress in male physiology through young and middle adulthood:
Testosterone and its cardiovascular effects are complex and deserve nuanced discussion. Testosterone is often assumed to be a purely cardiovascular risk-elevating hormone (explaining male-female differences), but the actual relationship is bidirectional. Higher physiological testosterone levels in men are associated with greater muscle mass (metabolically protective), more favorable insulin sensitivity in some contexts, and more aggressive competitive behaviors that may drive both beneficial (exercise, physical work) and harmful (risk-taking, stress) cardiovascular consequences. However, testosterone promotes red blood cell production (raising blood viscosity and thrombotic risk), stimulates LDL receptor downregulation in some settings (raising LDL), and the anabolic steroid versions of testosterone used in bodybuilding and performance enhancement are strongly associated with premature cardiovascular disease — including myocardial infarction in men under 35.
Estrogen deficiency relative to women is the mirror-image explanation: men lack the endothelial protection, anti-inflammatory effects, and favorable lipid effects that endogenous estrogen provides premenopausal women. The comparison makes clear that the female cardiovascular advantage during reproductive years is a real biological protection, not an artifact — and that its absence in men accounts for a meaningful portion of the sex difference in cardiovascular event timing.
Higher prevalence of key risk factors earlier in life: Men develop hypertension at younger ages than women on average — by age 45, male hypertension prevalence is approximately 45 percent versus 30 percent in women of the same age. Men smoke at higher rates globally. Men accumulate visceral fat more readily than premenopausal women for equivalent caloric surplus. Men have higher rates of heavy alcohol use. Each of these behavioral and metabolic differences adds to the cardiovascular risk gap between sexes that manifests as earlier events.
Erectile Dysfunction — The Cardiovascular Warning Signal Men Ignore
Erectile dysfunction (ED) is one of the most clinically important but consistently overlooked cardiovascular early warning signs in men. The penile arteries — whose dilation is required for erection — are among the smallest arterial beds in the body, and they develop atherosclerotic changes before the larger coronary arteries that supply the heart because smaller arteries require proportionally greater flow improvement to maintain function.
The Princeton Consensus — a panel of cardiovascular and sexual medicine specialists — established that new-onset ED in a man with no established cardiovascular disease should be treated as a potential early cardiovascular event and should prompt cardiovascular risk factor assessment. Multiple large studies confirm this relationship: men with ED have a 40 to 60 percent higher risk of cardiovascular events than men without ED of the same age, even after adjustment for traditional cardiovascular risk factors. In some analyses, ED has an independent cardiovascular predictive value comparable to a positive family history of premature cardiovascular disease or current smoking status.
The mechanism is direct: ED reflects endothelial dysfunction and early atherosclerotic narrowing of the penile vasculature, which are the same processes occurring simultaneously in the coronary and cerebral vasculature — typically 3 to 5 years ahead of clinical coronary artery disease symptoms. A man who develops ED in his mid-40s and dismisses it as a personal or psychological issue is potentially missing a 3 to 5-year window of opportunity to aggressively reduce cardiovascular risk before a coronary event occurs.
Men who report ED to their primary care providers should receive a full cardiovascular risk factor assessment — lipid panel, blood pressure measurement, fasting glucose, and 10-year ASCVD risk calculation — and the ED should be documented as a risk-enhancing factor in their cardiovascular risk profile. The irony is that the same risk factors driving the ED (endothelial dysfunction, atherosclerosis, poor metabolic health) also worsen cardiovascular prognosis — and interventions that address those risk factors (exercise, dietary improvement, LDL lowering, blood pressure control) often improve erectile function alongside cardiovascular outcomes.
Healthcare Avoidance in Men — The Behavioral Cardiovascular Risk Factor
Survey data consistently show that approximately 60 percent of men avoid seeing a doctor even when they believe something might be wrong with their health. Men are less likely than women to have a primary care provider, less likely to attend annual preventive visits, less likely to fill prescriptions for chronic medications, less likely to follow up after an abnormal test result, and less likely to call emergency services when experiencing cardiovascular symptoms. This systematic healthcare avoidance behavior is itself a cardiovascular risk factor — a behavioral pattern that allows risk factors to develop unidentified, persist untreated, and ultimately produce preventable events.
The reasons for healthcare avoidance in men are multifactorial and include: traditional masculinity norms that frame self-reliance and pain tolerance as virtues and healthcare-seeking as weakness; time constraints of demanding work schedules; lower health literacy about preventive care and the asymptomatic nature of major cardiovascular risk factors; and the practical inconvenience of healthcare access without established primary care relationships. Understanding these barriers is necessary for designing effective solutions — which means bringing cardiovascular risk assessment into the environments and encounters where men already are, rather than requiring men to change their behavior patterns to access care.
Several models have demonstrated success in reaching men who avoid traditional healthcare settings: workplace health screening programs that bring blood pressure measurement and lipid testing to work environments; barbershop-based health programs (the LA Barbershop Blood Pressure Study found significant blood pressure reduction in Black men through pharmacist-led treatment administered through barbershops); sports medicine and sports team health frameworks that frame cardiovascular screening as performance optimization; and primary care approaches that frame preventive visits around concrete actionable outcomes rather than abstract future risk reduction.
For men who have been avoiding healthcare, the most important first step is the simplest: establish a relationship with a primary care provider. A single comprehensive preventive visit at age 40 (or earlier if there are known risk factors or family history) establishes a cardiovascular baseline — lipid panel, blood pressure, glucose, ASCVD risk calculation — that is infinitely more valuable than no baseline at all. The conversation about cardiovascular risk and prevention that follows is most effective when framed around concrete actions and specific health goals rather than abstract risk percentages, and when the visit addresses immediate health concerns alongside preventive measures.
Testosterone Replacement Therapy and Cardiovascular Risk — What Men Need to Know
Low testosterone (hypogonadism) in men is increasingly diagnosed and increasingly treated with testosterone replacement therapy (TRT) — gels, injections, pellets, or patches that supplement endogenous testosterone to normal physiological levels. The cardiovascular implications of TRT have been a matter of clinical uncertainty and significant concern, and the evidence has evolved substantially in recent years.
Earlier observational studies suggested elevated cardiovascular risk from TRT, prompting the FDA in 2015 to require cardiovascular risk warning labels on all testosterone products. However, these observational studies had significant methodological limitations. The TRAVERSE trial — a large randomized controlled trial specifically designed to assess cardiovascular outcomes in hypogonadal men with high cardiovascular risk — published in 2023 found that testosterone therapy did not significantly increase the rate of major adverse cardiovascular events compared to placebo over an average 22-month follow-up. This finding has substantially reassured the field about TRT safety in appropriately selected patients.
What TRAVERSE also found, however, was that TRT significantly increased the rates of atrial fibrillation (hazard ratio 1.35), pulmonary embolism (hazard ratio 1.93), and acute kidney injury compared to placebo — findings that require clinical attention even in the absence of a significant MACE increase. The cardiovascular risk of TRT appears to be concentrated in specific complications — particularly thrombotic and arrhythmic events — rather than in coronary artery disease events per se. Men considering TRT should discuss these specific risks with their clinician, and men with established atrial fibrillation, prior venous thromboembolism, or severe cardiovascular disease require careful individual risk-benefit assessment.
Anabolic androgenic steroids (AAS) — used for bodybuilding, performance enhancement, or appearance — are categorically different from therapeutic TRT and carry substantially higher cardiovascular risks. Doses used in non-therapeutic AAS typically far exceed the physiological range achieved with TRT, and AAS use is associated with left ventricular hypertrophy, reduced cardiac systolic function, accelerated atherosclerosis, myocardial infarction in young men, and sudden cardiac death. AAS-using men are commonly identified in sudden cardiac death registries at ages well below 40, and this risk is dose-dependent and cumulative with duration of use.
Men’s Cardiovascular Prevention Priorities — A Practical Framework
The most effective cardiovascular prevention program for men acknowledges the behavioral reality of male healthcare engagement while delivering the evidence-based interventions that make the greatest difference. The core priorities, sequenced by impact:
Quit smoking — if applicable. The cardiovascular benefit of smoking cessation is larger, faster, and more certain than any other single behavioral change. Combination pharmacotherapy (varenicline plus nicotine replacement) with behavioral support achieves 25 to 35 percent 12-month abstinence rates per attempt. Men who smoke face 2 to 4 times the cardiovascular event rates of non-smokers, and half of that excess risk disappears within one year of quitting.
Establish healthcare engagement — find a primary care provider and attend a comprehensive preventive visit. Know your numbers: LDL, blood pressure, fasting glucose, and waist circumference provide the four most actionable cardiovascular data points. Know your 10-year ASCVD risk score. Have a follow-up plan based on the findings.
Build and sustain an exercise habit — 150 minutes per week of moderate-intensity aerobic activity plus 2 sessions of resistance training per week. Exercise reduces every major cardiovascular risk factor simultaneously and is the closest thing to a cardiovascular polypill available without a prescription. Men who frame exercise as performance optimization — not as disease prevention — are more likely to sustain it.
Address alcohol consumption — Men drink at higher rates than women and are more likely to be heavy or binge drinkers. Current evidence does not support a cardiovascular benefit from any level of alcohol consumption. Reducing from heavy drinking (more than 3 drinks per day) to light drinking produces measurable blood pressure reduction and AFib risk reduction. Complete abstinence is not necessary for cardiovascular benefit, but drinking less rather than more is the unambiguously evidence-supported position.
Take ED seriously as a cardiovascular signal — New-onset ED in a man under 60 without an obvious psychological or pharmacological cause should prompt cardiovascular risk assessment. Addressing the underlying cardiovascular risk factors often improves erectile function alongside cardiovascular prognosis — removing the false choice between addressing ED “cosmetically” with PDE5 inhibitors versus addressing its cardiovascular substrate.
The American Heart Association’s heart disease prevention resources provide comprehensive cardiovascular risk factor guidance. The CDC’s men and heart disease resources offer epidemiological context and prevention recommendations. The NHLBI heart attack information covers recognition, risk factors, and prevention.
Related reading: What Causes Heart Disease? | Major Risk Factors for Heart Disease | How to Lower Heart Disease Risk | Heart Disease Prevention for Women | Heart Attack Prevention
Sources
- Lerner DJ, Kannel WB. Patterns of Coronary Heart Disease Morbidity and Mortality in the Sexes. Am Heart J. 1986;111(2):383-390.
- Vlachopoulos C, et al. Erectile Dysfunction as a Cardiovascular Risk Factor. Curr Vasc Pharmacol. 2013;11(6):811-821.
- Victor RG, et al. A Cluster-Randomized Trial of Blood-Pressure Reduction in Black Barbershops (LA Barbershop Study). N Engl J Med. 2018;378(14):1291-1301.
- Lincoff AM, et al. Cardiovascular Safety of Testosterone-Replacement Therapy (TRAVERSE). N Engl J Med. 2023;389(2):107-117.
- Nieschlag E, Vorona E. Mechanisms in Endocrinology: Medical Consequences of Doping with Anabolic Androgenic Steroids. Eur J Endocrinol. 2015;173(2):R47-R58.
- Galdas PM, et al. Men and Health Help-Seeking Behaviour. J Adv Nurs. 2005;49(6):616-623.
Sleep Apnea in Men — The Most Underdiagnosed Male Cardiovascular Risk Factor
Obstructive sleep apnea is substantially more prevalent in men than women — affecting an estimated 26 to 34 percent of middle-aged men versus 17 to 28 percent of middle-aged women — and it carries the same cardiovascular consequences regardless of sex: treatment-resistant hypertension, elevated atrial fibrillation risk, nocturnal sympathetic surges, and systemic inflammation. What makes sleep apnea particularly important in the context of male cardiovascular prevention is the degree of underdiagnosis: up to 80 percent of men with clinically significant OSA are undiagnosed, making it one of the largest unaddressed cardiovascular risk burdens in men specifically.
Several features of male OSA presentation explain both its higher prevalence and its frequent underdiagnosis. Men with OSA more commonly present with the classic phenotype — loud snoring, witnessed apneas, obesity, excessive daytime sleepiness — which should facilitate diagnosis. Yet many men dismiss these symptoms as normal (“I’ve always snored”) or consider daytime sleepiness an acceptable consequence of busy work schedules. Many men’s bed partners are the first to recognize the symptom burden (witnessed apneas, frequent arousals, significant snoring) and urge evaluation — yet this observation may not translate into a medical visit for months or years.
For men with hypertension that is difficult to control on two or more medications, the STOP-BANG questionnaire should be completed and referral for sleep evaluation considered as a first-line diagnostic step — not an afterthought. For men with new-onset atrial fibrillation, OSA evaluation is recommended in current electrophysiology guidelines as part of AF management, because untreated OSA substantially reduces the effectiveness of rhythm control strategies including cardioversion and catheter ablation. For men who use CPAP after diagnosis, the cardiovascular benefits — improved blood pressure control, reduced AFib burden, improved heart rate variability — can be substantial and are typically apparent within weeks of achieving consistent adherence.
Occupational Cardiovascular Risks — What High-Demand Jobs Do to the Heart
Men disproportionately occupy high-cardiovascular-risk occupational categories — both physically demanding jobs and high psychological-stress professional roles — each carrying distinct cardiovascular risk mechanisms.
Physically demanding occupations (construction, firefighting, police work, military service, commercial transportation) carry cardiovascular risks through several mechanisms: heavy acute physical exertion in men with unidentified underlying cardiovascular disease (a major cause of occupational sudden cardiac death, particularly in firefighters and construction workers); shift work and irregular sleep schedules that disrupt circadian rhythm and elevate blood pressure and glucose; occupational noise exposure (chronic high-volume noise is independently associated with hypertension and cardiovascular events, through stress response activation); and occupational chemical exposures (carbon monoxide, diesel exhaust particulates, and certain solvents have cardiovascular toxicity at sustained occupational exposure levels).
High-demand professional roles (executive, financial, legal, medical, emergency response) carry cardiovascular risk through the occupational stress mechanisms described in other articles — job strain (high demand, low control), effort-reward imbalance, long working hours, and sleep disruption. Men in high-earning but high-demand professional roles often display a characteristic cardiovascular risk pattern: excellent healthcare access and knowledge but poor behavioral adherence (skipping exercise due to work demands, poor dietary habits due to client meals and travel, high alcohol consumption as social lubricant or stress management, chronic sleep curtailment). Recognizing that these behavioral patterns carry real cardiovascular consequences — not simply “occupational hazards” to be accepted as the cost of career success — is the first step toward addressing them.
For men in high-cardiovascular-risk occupations, several specific recommendations apply: periodic cardiovascular fitness testing (standard in some high-demand occupations like firefighting but not others) provides a concrete measure of cardiac reserve and can identify underlying coronary artery disease before it manifests as an event during exertion; blood pressure monitoring at work using a personal monitor identifies hypertension developing under occupational stress that may not be apparent in office blood pressure readings; and occupational health programs that provide access to cardiovascular screening without requiring men to navigate general healthcare systems have demonstrated higher participation rates in male-dominated occupational settings.
Diet, Weight, and Visceral Fat in Men — The Belly Fat Problem
Men accumulate visceral fat (intra-abdominal fat surrounding the organs) more readily than premenopausal women for equivalent caloric surplus, and visceral fat is the metabolically dangerous fat type that drives insulin resistance, systemic inflammation, dyslipidemia, and hypertension. A man who has gained 15 to 20 pounds since his 20s — a pattern so common it is normalized — has almost certainly accumulated significant visceral fat that is actively elevating cardiovascular risk, even if his BMI still falls in the “overweight” rather than “obese” range.
Waist circumference above 40 inches (102 cm) in men identifies elevated visceral adiposity with established cardiovascular risk associations. The simple rule of measuring one’s waist at the level of the navel — not the belt line, which underestimates waist circumference — takes 30 seconds and provides cardiovascular information that BMI alone cannot capture. Men with waist circumference above 40 inches who have not discussed this with a clinician as a cardiovascular risk factor are managing only part of their cardiovascular risk profile.
Dietary patterns that are particularly common in men and particularly cardiovascularly harmful include: high processed meat consumption (hot dogs, sausage, bacon, deli meats — associated with 18 percent higher cardiovascular event rates per daily serving in large meta-analyses, largely through sodium and nitrate content); excessive fast food and restaurant meal frequency (typical restaurant meals contain 2 to 3 times the daily recommended sodium); and high-sugar beverage consumption (sugar-sweetened beverages are independently associated with hypertension, type 2 diabetes, and cardiovascular events through multiple mechanisms including hepatic lipogenesis and inflammatory pathways). None of these dietary patterns require dramatic overhaul to improve cardiovascular risk — reducing frequency of processed meat, substituting water or unsweetened beverages for sugary drinks, and cooking more meals at home produces meaningful cardiovascular benefit without requiring a complete dietary transformation.
Heart disease prevention for men ultimately reduces to a simple core message: take cardiovascular health as seriously as any other performance goal or professional achievement. The same intentional effort that men bring to career advancement, athletic competition, or financial planning — applied to regular exercise, routine healthcare engagement, cardiovascular risk factor monitoring, and evidence-based lifestyle management — produces dramatically different cardiovascular trajectories than the passive approach that characterizes male healthcare engagement in most current populations. The biology of elevated male cardiovascular risk is not destiny. It is a starting condition that is highly responsive to informed, sustained action.